Condition

Dystrophinopathy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Dystrophinopathy clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Dystrophinopathy clinical trials

StudyPhaseWhereStatusRegistered
Duchenne/Becker Muscular Dystrophy EHR Data Linkage — Little Rock, Arkansas and 10 other locations Recruiting May 27, 2026
Virtual Park for Children: Dual-Task Training with Virtual Reality — Bosisio Parini, LC and 3 other locations Recruiting May 12, 2026
An online registry for Duchenne and Becker muscular dystrophy patients — Washington D.C., District of Columbia Recruiting Feb 24, 2014

All recruiting trials (3)

Related topics

Becker Muscular DystrophyDystrophinopathy Symptomatic Female CarrierCongenital MyopathiesDuchenne Muscular DystrophyDuchenne Muscular Dystrophy (DMD)Muscular Dystrophies

Quick answers

How many Dystrophinopathy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.